Host-directed Therapy

Host-Directed Therapy is a therapeutic strategy that modulates host immune responses and cellular functions to enhance pathogen clearance, limit tissue damage, and promote disease resolution, distinguishing it from pathogen-targeted approaches by focusing on the host’s biological mechanisms rather than direct antimicrobial activity.

221

Publications

11.5K

Citations

1.9K

Authors

632

Institutions

Publications per year

2017–2026

178

Authors

1.9K

  1. BB
    Bruno B. Andrade

    Fundação Oswaldo Cruz, Brazil

    7 publications · 1.5K citations

    7

    h-index

  2. SH
    Stefan H. E. Kaufmann

    Max Planck Institute for Infection Biology, Germany

    6 publications · 437 citations

    6

    h-index

  3. TH
    Tom H. M. Ottenhoff

    Leiden University Medical Center, Netherlands

    6 publications · 296 citations

    6

    h-index

  4. WR
    William R. Bishai

    Johns Hopkins University, United States

    6 publications · 183 citations

    6

    h-index

  5. AZ
    Alimuddin Zumla

    University College London, United Kingdom

    6 publications · 548 citations

    6

    h-index

1–5 of 1.9K

Venues

  1. Frontiers in Immunology

    17 publications · 628 citations

    15

    h-index

  2. Scientific Reports

    14 publications · 539 citations

    14

    h-index

  3. The Journal of Infectious Diseases

    JID · 13 publications · 655 citations

    12

    h-index

  4. Nature Communications

    7 publications · 583 citations

    7

    h-index

  5. Antimicrobial Agents and Chemotherapy

    AAC · 7 publications · 151 citations

    7

    h-index

1–5